400-921-8278
| Catalog_no | ADMC0253 |
| Product_name | BAY 59-7939 (Rivaroxaban) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 780.00/1340.00/2400.00 |
| Specificity | Target: Factor Xa. Fields: Rivaroxaban (Xarelto; BAY 59-7939) is a novel, oral, direct Factor Xa (FXa) inhibitor in late-stage development for the prevention and treatment of thromboembolic disorders. IC50: 0.7 nM (FXa)[1] Ki: 0.4 nM (FXa)[1] |
| Dilution | IC50: 0.7 nM (FXa)[1] Ki: 0.4 nM (FXa)[1] |
| Purification | >98% |
| Concentration | 靶点：Factor Xa;IC50： 0.7 nM (FXa)[1] Ki: 0.4 nM (FXa)[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| Observed_band | 435.88 |
| Notes | Rivaroxaban (Xarelto; BAY 59-7939) is a novel, oral, direct Factor Xa (FXa) inhibitor in late-stage development for the prevention and treatment of thromboembolic disorders. IC50: 0.7 nM (FXa)[1] Ki: 0.4 nM (FXa)[1] |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
